Circularly polarized luminescence (CPL) enables promising applications in asymmetric photonics. However, the performances of CPL molecules do not yet meet the requirements of these applications. The shortcoming originates from the trade-off in CPL between the photoluminescence quantum yield (PLQY) and the photoluminescence dissymmetry factor (g PL). In this study, we developed a molecular strategy to circumvent this trade-off. Our approach takes advantage of the strong propensity of [Pt(N^C^N)Cl], where the N^C^N ligand is 1-(2-oxazoline)-3-(2-pyridyl)phenylate, to form face-to-face stacks. We introduced chiral substituents, including (S)-methyl, (R)- and (S)-isopropyl, and (S)-indanyl groups, into the ligand framework. This asymmetric control induces torsional displacements that give homohelical stacks of the Pt(II) complexes. X-ray single-crystal structure analyses for the (S)-isopropyl Pt(II) complex reveal the formation of a homohelical dimer with a Pt···Pt distance of 3.48 Å, which is less than the sum of the van der Waals radii of Pt. This helical stack elicits the metal–metal-to-ligand charge-transfer (MMLCT) transition that exhibits strong chiroptical activity due to the electric transition moment making an acute angle to the magnetic transition moment. The PLQY and g PL values of the MMLCT phosphorescence emission of the (S)-isopropyl Pt(II) complex are 0.49 and 8.4 × 10–4, which are improved by factors of ca. 6 and 4, respectively, relative to the values of the unimolecular emission (PLQY, 0.078; g PL, 2.4 × 10–4). Our photophysical measurements for the systematically controlled Pt(II) complexes reveal that the CPL amplifications depend on the chiral substituent. Our investigations also indicate that excimers are not responsible for the enhanced chiroptical activity. To demonstrate the effectiveness of our approach, organic electroluminescence devices were fabricated. The MMLCT emission devices were found to exhibit simultaneous enhancements in the external quantum efficiency (EQE, 9.7%) and the electroluminescence dissymmetry factor (g EL, 1.2 × 10–4) over the unimolecular emission devices (EQE, 5.8%; g EL, 0.3 × 10–4). These results demonstrate the usefulness of using the chiroptically active MMLCT emission for achieving an amplified CPL.
Electrides, which have excess anionic electrons, are solid-state sources of solvated electrons that can be used as powerful reducing agents for organic syntheses. However, the abrupt decomposition of electrides in organic solvents makes controlling the transfer inefficient, thereby limiting the utilization of their superior electron-donating ability. Here, we demonstrate the efficient reductive transformation strategy which combines the stable two-dimensional [Gd2C]2+·2e– electride electron donor and cyclometalated Pt(II) complex photocatalysts. Strongly localized anionic electrons at the interlayer space in the [Gd2C]2+·2e– electride are released via moderate alcoholysis in 2,2,2-trifluoroethanol, enabling persistent electron donation. The Pt(II) complexes are adsorbed onto the surface of the [Gd2C]2+·2e– electride and rapidly capture the released electrons at a rate of 107 s–1 upon photoexcitation. The one-electron-reduced Pt complex is electrochemically stable enough to deliver the electron to substrates in the bulk, which completes the photoredox cycle. The key benefit of this system is the suppression of undesirable charge recombination because back electron transfer is prohibited due to the irreversible disruption of the electride after the electron transfer. These desirable properties collectively serve as the photoredox catalysis principle for the reductive generation of the benzyl radical from benzyl halide, which is the key intermediate for dehalogenated or homocoupled products.
Achieving large external quantum efficiencies, narrow bandwidths, and a long operational lifetime at high brightness remains the largest hurdle to developing organic blue‐emitting devices. Here, a material strategy is demonstrated that can meet these conditions. The strategy is based on linear heteroleptic Au(I) complex exciton harvesters and multiresonance thermally activated delayed fluorescence (MR‐TADF) emitters. The organic electroluminescence devices produce blue emission with Commission Internationale de l'Eclairage chromaticity coordinates of (0.108, 0.160), a narrow full‐width at half‐maximum value of 20 nm, and a maximum external quantum efficiency (EQE) as high as 30.2%. Notably, the EQE value remains 22.2% at 2000 cd m−2, whereas conventional control devices with an organic exciton harvester suffer from huge roll‐offs in quantum efficiency. An additional benefit of the device is a one‐order‐of‐magnitude improvement in its operational lifetime compared with that of the control device. Finally, the investigations reveal that the improvements are attributable to the unique ability of the Au(I) complexes for ultrafast triplet exciton harvest. In addition, the Au(I) complexes can facilitate Förster energy transfer to the MR‐TADF emitter, with effective suppression of hazardous triplet–triplet Dexter energy transfer. It is believed that the research is helpful in commercializing high‐efficiency and stable blue electroluminescence devices.
A distinctive sustainable approach has been developed to afford highly functionalized CF3-hydroquinone derivatives as potent biologically active molecules. The synthetic protocol involves photoirradiation of a mixture of easily accessible benzoquinones...
Glutathione (GSH) is an essential molecule that plays a pivotal role in maintaining intracellular redox homeostasis, as well as other physiological processess. However, the chemical mechanisms underlying the GSH-induced processes...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.